Plasma levels of 16 alpha-hydroxypregnenolone, 16 alpha-hydroxyprogesterone and 16 alpha-hydroxydehydroepiandrosterone in the fetus and neonates. 1979

K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi

Simultaneous determination of unconjugated 16 alpha-hydroxypregnenolone (16 alphaOH-Preg), 16 alpha-hydroxyprogesterone (16 alphaOH-Prog) and 16 alpha-hydroxydehydroepiandrosterone (16 alphaOH-DHEA) in fetal and neonatal plasma was performed utilizing a newly developed radioimmunoassay. In all neonates, the three 16 alpha-hydroxysteroid levels were consistently higher in umbilical cord plasma than in the maternal peripheral circulation. 16 alpha-OH-Preg in the umbilical arterial plasma increased from 11.2 +/- 3.1 at 24 weeks to 29.7 +/- 12.0 ng/ml at term, 16 alphaOH-Prog from 15.5 +/- 3.2 to 34.3 +/- 11.0 ng/ml and 16 alphaOH-DHEA from 5.1 +/- 1.2 to 5.9 +/- 1.0 ng/ml. In the anencephalic neonates, only 16 alphaOH-Preg showed an increase pattern under ACTH priming. 16 alpha-OH-Preg levels for normal full term neonates remain relatively constant at the first 24 hr and show a slight decrease at 3 days post partum. In small full term neonates, 16 alphaOH-Preg levels in umbilical arterial plasma are considerably higher than in normal neonates and remain at roughly equivalent levels for the first 5 days post partum. 16 alphaOH-Prog and 16 alphaOH-DHEA levels in umbilical arterial plasma in normal and small full term neonates are almost equal and both groups show a rapid decrease during the first 24 hr. Comparison with findings of the three 16 alpha-hydroxysteroids in fetal and neonatal plasma is discussed.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D005260 Female Females
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006907 17-alpha-Hydroxypregnenolone A 21-carbon steroid that is converted from PREGNENOLONE by STEROID 17-ALPHA-HYDROXYLASE. It is an intermediate in the delta-5 pathway of biosynthesis of GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS. 17 alpha-Hydroxypregnenolone,17-Hydroxypregnenolone,17-Hydroxypregnenolone, (3alpha)-Isomer,17-Hydroxypregnenolone, (3beta,13alpha)-Isomer,17-Hydroxypregnenolone, (3beta,13alpha,17alpha)-Isomer,17-Hydroxypregnenolone, (3beta,17alpha)-Isomer,17alpha-Hydroxypregnenolone,Hydroxypregnenolone,17 Hydroxypregnenolone,17 alpha Hydroxypregnenolone,17alpha Hydroxypregnenolone

Related Publications

K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
October 1969, The Journal of clinical endocrinology and metabolism,
K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
June 1971, Steroids,
K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
June 1985, Nihon Naibunpi Gakkai zasshi,
K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
August 1973, Endokrinologie,
K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
October 1969, The Journal of clinical endocrinology and metabolism,
K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
May 1964, Biochimica et biophysica acta,
K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
September 1986, Annals of clinical biochemistry,
K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
March 1968, The Journal of clinical endocrinology and metabolism,
K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
March 1966, Biochemistry,
K Den, and T Haruyama, and H Hagiwara, and K T Fujii, and A Kambegawa, and T Takami, and T Yoshida, and S Takagi
November 1976, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!